Literature DB >> 12095538

Upregulation of small GTPase RhoA in the basilar artery from diabetic (mellitus) rats.

L Miao1, J W Calvert, J Tang, J H Zhang.   

Abstract

The goal of this study was to determine whether RhoA, a small GTPase, might be involved in the development of cerebral pathogenesis in diabetes. Male SD rats (n = 120) were divided into six groups: diabetic for 2, 4, 8 weeks, and an age-matched control group. Diabetes was induced by intravenous injection of streptozotocin (50 mg/kg). RhoA mRNA expression in basilar artery was measured by competitive RT-PCR. RhoA mRNA level was significantly increased in 4 weeks (184.1 +/- 28.5%, n = 7) and 8 weeks (218.7 +/- 24.5%, n = 7) after STZ injection compared to the age matched control basilar arteries (P < 0.05). Western blot was used to measure the membrane binding RhoA level to represent the activity of RhoA. We found that RhoA activity was strikingly increased in the diabetic basilar artery (n = 10 in each groups) compared to control basilar artery after STZ injection. Our data demonstrated that there was an upregulation of RhoA in the basilar artery of STZ induced diabetic rats, suggesting that RhoA might be involved in the cerebral vascular pathogenesis during diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095538     DOI: 10.1016/s0024-3205(02)01827-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats.

Authors:  R Komers; T T Oyama; D R Beard; S Anderson
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

2.  PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway.

Authors:  Kirtiman Srivastava; Beili Shao; Ulvi Bayraktutan
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

Review 3.  Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature.

Authors:  Adviye Ergul; Weiguo Li; Mostafa M Elgebaly; Askiel Bruno; Susan C Fagan
Journal:  Vascul Pharmacol       Date:  2009-03-01       Impact factor: 5.773

4.  Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.

Authors:  James T Pearson; Mathew J Jenkins; Amanda J Edgley; Takashi Sonobe; Mandar Joshi; Mark T Waddingham; Yutaka Fujii; Daryl O Schwenke; Hirotsugu Tsuchimochi; Misa Yoshimoto; Keiji Umetani; Darren J Kelly; Mikiyasu Shirai
Journal:  Cardiovasc Diabetol       Date:  2013-08-01       Impact factor: 9.951

5.  RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels.

Authors:  Zhijun Sun; Xing Wu; Weiping Li; Hui Peng; Xuhua Shen; Lu Ma; Huirong Liu; Hongwei Li
Journal:  BMC Cardiovasc Disord       Date:  2016-10-11       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.